Search results
Toshio Mochizuki. University of Tokyo: Bunkyo-ku, Tokyo, JP. 2006-04-01 to 2009-03-31 | Project Associate Professor (Microsoft Chair of Educational Environments and Technology, Center for Research and Development of Higher Education) Employment.
Toshio MOCHIZUKI, Associate Professor | Cited by 218 | of Senshu University, Tokyo | Read 72 publications | Contact Toshio MOCHIZUKI
Jun 30, 2008 · Toshio Mochizuki, Senshu University, Network and Information Department, Faculty Member. Studies Constructivism, Social Support, and Computer Supported Collaborative Learning (CSCL). Dr. Mochizuki is an associate professor at School of Network and
Oct 27, 2022 · Toshio Mochizuki. Scientific Reports 12, Article number: 18056 ( 2022 ) Cite this article. 1243 Accesses. 5 Citations. Metrics. Presently, only personal or family history of intracranial...
- Hiroshi Kataoka
Mar 25, 2018 · Abstract. We report a case of glomerulonephritis with monoclonal immunoglobulin (Ig) A deposits as a form of monoclonal gammopathy of renal significance (MGRS) caused by monoclonal immunoglobulins without blood disorders in a 41-year-old woman.
- Keisuke Sato, Shiho Makabe, Yuko Iwabuchi, Kaori Kojima, Masayo Sato, Hiroshi Kataoka, Takahito Mori...
- 2018
Jul 6, 2021 · Tolvaptan is a vasopressin type 2 receptor antagonist and has been used to treat autosomal dominant polycystic kidney disease (ADPKD) since 2014. There has been limited real-world data on the safety and efficacy of tolvaptan. Methods.
Jul 23, 2016 · Dr. Toshio Mochizuki, Division of Clinical Research for Polycystic Kidney Disease, Department of Medicine, Kidney Center, Tokyo Women's Medical University, 8–1 Kawada-cho, Shinjuku-ku, Tokyo 162–8666, Japan.
